holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 6M/2022 (01/01/22 -30/06/22
-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 6M/2022 (01/01/22 -30/06/22) 6M/2021 (01/01/21 -30/06/21) 2021 (01/01/21 -31/12/21) 2020 (01
Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 6M/2022 (01/01/22 -30/06/22) 6M/2021 (01/01/21 -30/06/21) 2021 (01/01/21 -31/12/21
440.42 -0.84 -0.19 436.01 434.47 1.54 0.35 Profit (Owners of the parent) 33.33 70.57 -37.24 -52.77 48.54 71.49 -22.95 -32.11 Total Comprehensive Income for the Period 28.63 64.27 -35.64 -55.46 In overall
subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
follows: Statements of Comprehensive Income for the 1st Quarter Ended March 31, 2019 Revenue from Hospital Operations Revenue from hospital operations in the first quarter of 2019 (“1Q’19”) was THB 445.88
. Statement of comprehensive income Revenue from hospital operations The Company booked revenue from hospital operations amounting to Baht 217.32 million and Baht 394.03 million for the six-month period ended
year 2019 at Baht 0.42 per share or equivalent to 61.27% of net profit. The dividend will be paid on 6 September 2019. Statement of Comprehensive Income For the three-month period ended 30 June 1/3
components of shareholders’ equity increased by Baht 175 million due to profit from share of other comprehensive income of associates - net of income tax. In addition, the Company and its subsidiaries paid
audited by the independent auditor as follows: Statements of Comprehensive Income for the 1st Quarter of 2018 Note: During 1Q’17, the subsidiary has recorded income incurred from deferred tax for the amount